跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/EUCTR2007-001509-11-DE
EUCTR2007-001509-11-DE进行中（未招募）不适用

A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). - STRATEC

Institut de Recherches Internationales Servier0 个研究点目标入组 80 人开始时间: 2008年3月5日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
相关药物

试验速览

阶段
不适用
状态
进行中（未招募）
入组人数
80
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • •- Women of at least 50 years
  • •- Postmenopausal for at least 5 years
  • •- Osteoporosis
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range

排除标准

  • •- Evolutive cancers during the past 5 years with a risk of bone metastases
  • •- BMI less than 18 or higher than 30 kg/m²
  • •- Severe malabsorption

研究者

相似试验

进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). - NDMedDRA version: 9.1Level: LLTClassification code 10031285Term: Osteoporosis postmenopausalpostmenopausal osteoporosis
EUCTR2007-001509-11-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER80
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT).
EUCTR2007-001509-11-SEInstitut de Recherches Internationales Servier148
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). - STRATECPost-menopausal osteoporosisMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2007-001509-11-GRInstitut de Recherches Internationales Servier80
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2g per day of strontium ranelate versus alendronate 70mg per week in women with postmenopausal osteoporosis on bone microarchitecture measured by high resolution peripheral-Quantitative Computed Tomography (p-QCT).
EUCTR2006-002732-22-DEInstitut de Recherches Internationales Servier72
进行中（未招募）
不适用
A Clinical Trial to Evaluate the Effects of the drug Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease, and infection with the bacteria Pseudomonas aeruginosa (AIR-CF4)
EUCTR2015-000395-97-Outside-EU/EEAGilead Sciences, Inc.157